Suppr超能文献

1,3,4-噁二唑及其衍生物:抗癌活性的最新研究进展综述。

1,3,4-oxadiazole and its derivatives: A review on recent progress in anticancer activities.

机构信息

Pharmacy College, UPUMS, Etawah, UP, India.

Institute of Pharmaceutical Research, GLA University, Mathura, UP, India.

出版信息

Chem Biol Drug Des. 2021 Mar;97(3):572-591. doi: 10.1111/cbdd.13795. Epub 2020 Sep 27.

Abstract

The 1,3,4-oxadiazole nucleus is a biologically imperative scaffold possesses numerous biological activities. The broad and potent activity of 1,3,4-oxadiazole and their derivatives has established them as important pharmacological scaffolds especially in the treatment of cancer disease. Several di-, tri-, aromatic, and heterocyclic substituted 1,3,4-oxadiazole derivatives have been reported to possess potent anticancer activity. These substituted 1,3,4-oxadiazoles had shown different mechanism of action and participated in anticancer drug discovery and development. This review is complementary to earlier reviews and aims to review the work reported on anticancer activities of 1,3,4-oxadiazole derivatives from year 2000 to the beginning of 2020.

摘要

1,3,4-恶二唑核是一种具有重要生物学意义的骨架,具有多种生物学活性。1,3,4-恶二唑及其衍生物广泛而强大的活性使它们成为重要的药理学支架,特别是在癌症治疗方面。已经报道了几种二、三、芳基和杂环取代的 1,3,4-恶二唑衍生物具有很强的抗癌活性。这些取代的 1,3,4-恶二唑已经显示出不同的作用机制,并参与了抗癌药物的发现和开发。本篇综述是对早期综述的补充,旨在综述 2000 年至 2020 年初报道的 1,3,4-恶二唑衍生物的抗癌活性研究工作。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验